BOUNDLESS BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.53 USD | +2.69% |
|
-3.74% | 0.00% |
| Apr. 22 | Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target | MT |
| Apr. 22 | Piper Sandler Starts Audentes Therapeutics With Overweight Rating, $20 Price Target | MT |
Chart calendar Boundless Bio, Inc.
3494dae6d254023.Tr4Ah8z8JVkoG64TiWcZL9KxiU3tpFNG9VYvMKPXacI.ffI09YWfCDBRXNoj6j8pG-rlygOZ6wIng3toZ5CjRK08-U3Fjp5uHxpiyQ~b1c059f355af597cb01fc6c658e291f9
Upcoming events on Boundless Bio, Inc.
No events available
Past events on Boundless Bio, Inc.
| 2024-05-13 01:00 pm | Citizens JMP Life Sciences Conference |
| 2024-05-13 07:00 am | Q1 2024 Earnings Release |
| 2024-04-09 04:30 pm | American Association for Cancer Research Meeting - Poster Number: 14 |
| 2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Poster Number: 9 |
| 2024-04-07 04:30 pm | American Association for Cancer Research Meeting - Poster Number: 23 |
Annual results
| Fiscal Period | December | 2023 | 2024 |
|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -72,7 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -73,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -72,0 |
|
Net income Million USD | Released Forecast Spread | -49,4 | -68,1 |
|
EPS USD | Released Forecast Spread | -2,08 | -3,35 |
| Announcement Date | 06/03/24 | - |
Quarterly results
| Fiscal Period | December | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -16,9 -15,4 -9.51% | -17,3 | -18,9 | -19,9 | -22,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,4 -16,3 5.05% | -17,5 | -18,7 | -19,6 | -21,1 |
|
Net income Million USD | Released Forecast Spread | -15,4 -15,6 1.3% | -16,9 | -18,0 | -18,8 | -21,1 |
|
EPS USD | Released Forecast Spread | -12,3 -0,74 -1569.39% | -0,73 | -0,77 | -0,80 | -0,89 |
| Announcement Date | 13/05/24 | - | - | - | - |
More events
Past sector events for Boundless Bio, Inc.
| Today | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | CELCUITY INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
| 2024-05-14 07:00 am | IMMATICS N.V.: Q1 2024 Earnings Release |
| 2024-05-13 | PEPTIDREAM INC.: Q1 2024 Earnings Release |
| 2024-05-14 01:00 am | NYKODE THERAPEUTICS: Q1 2024 Earnings Release |
| 2024-05-13 | ABL BIO INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BOLD Stock
- Calendar Boundless Bio, Inc.
